These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 7996525
41. [Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: a critical review]. Rozenberg P. J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):221-30. PubMed ID: 11397997 [Abstract] [Full Text] [Related]
42. The efficacy of terbutaline and magnesium sulfate in the management of preterm labor. Surichamorn P. J Med Assoc Thai; 2001 Jan; 84(1):98-104. PubMed ID: 11281506 [Abstract] [Full Text] [Related]
48. Retrospective analysis of the effects of ritodrine and terbutaline in the management of preterm labor. Weiss MA. Clin Pharm; 1982 Jan; 1(5):453-6. PubMed ID: 7184677 [Abstract] [Full Text] [Related]
49. A comparison of gestational days gained with oral terbutaline versus continuous subcutaneous terbutaline in women with twin gestations. Lam F, Bergauer NK, Coleman SK, Stanziano GJ, Jacques D. J Perinatol; 2000 Jan; 20(7):408-13. PubMed ID: 11076323 [Abstract] [Full Text] [Related]
50. Continuous subcutaneous terbutaline pump therapy for premature labor: safety and efficacy. Moise KJ, Sala DJ, Zurawin RK, Cano LE, Hesketh DE, Carpenter RJ. South Med J; 1992 Mar; 85(3):255-60. PubMed ID: 1546349 [Abstract] [Full Text] [Related]
51. The effect of tocolytic use in the management of symptomatic placenta previa. Besinger RE, Moniak CW, Paskiewicz LS, Fisher SG, Tomich PG. Am J Obstet Gynecol; 1995 Jun; 172(6):1770-5; discussion 1775-8. PubMed ID: 7778631 [Abstract] [Full Text] [Related]
52. Success rate of terbutaline in inhibiting preterm labor for 48 h. Theplib A, Phupong V. J Matern Fetal Neonatal Med; 2016 Mar; 29(5):841-4. PubMed ID: 25758629 [Abstract] [Full Text] [Related]
53. Clinical and economic outcomes of preterm labor management: inpatient vs outpatient. Ambrose S, Rhea DJ, Istwan NB, Collins A, Stanziano G. J Perinatol; 2004 Aug; 24(8):515-9. PubMed ID: 15141268 [Abstract] [Full Text] [Related]
54. The validity of cervical dilation as an indication of true labor between 32 and 36 weeks 6 days of gestation. Jain S, Earhart A, Ruddock N, Wen T, Hankins GD, Saade GR. Am J Obstet Gynecol; 2007 Oct; 197(4):431.e1-3. PubMed ID: 17904991 [Abstract] [Full Text] [Related]
55. Morbidity caused by terbutaline infusion pump therapy. Levy DL. Am J Obstet Gynecol; 1994 Jun; 170(6):1835. PubMed ID: 8203446 [No Abstract] [Full Text] [Related]
56. Magnesium sulfate and beta-mimetic dual-agent tocolysis in preterm labor after single-agent failure. Ogburn PL, Hansen CA, Williams PP, Butler JC, Joseph MS, Julian TM. J Reprod Med; 1985 Aug; 30(8):583-7. PubMed ID: 2864441 [Abstract] [Full Text] [Related]
57. Randomized comparison of intravenous nitroglycerin and subcutaneous terbutaline for external cephalic version under tocolysis. El-Sayed YY, Pullen K, Riley ET, Lyell D, Druzin ML, Cohen SE, Chitkara U. Am J Obstet Gynecol; 2004 Dec; 191(6):2051-5. PubMed ID: 15592291 [Abstract] [Full Text] [Related]